Published in Cancer Weekly, October 15th, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) tumor vaccines have shown promise for their ability to stimulate immune system response against cancer. Officials at the Immune Response Corporation in Carlsbad, California, recently announced they have enhanced GM-CSF tumor vaccine cancer fighting ability by expressing GM-CSF as a membrane bound form (mbGM-CSF). According to them, the membrane bound form of GM-CSF boosts immunogenicity.
The premise behind the novel design is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.